FDA
-
-
-
-
-
-
-
BrainsWay Presents Positive Data from Largest Real-World Study of Deep TMS™ in Patients with Comorbid PTSD and Major Depressive Disorder
-
-
-
-
-
-
-
BrainsWay Announces Minority-Stake Investment in Hopemark Health
-
-
-
-
-
-
-
BrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of Proliv™Rx System for MDD
-
-
-
-
-
-
-
BrainsWay invests $1 million in Canadian mental health provider
-
-
-
-
-
-
-
Highmark drafts coverage policy for BrainsWay accelerated depression treatment
-
-
-
-
-
-
-
BrainsWay to Host Virtual Analyst & Investor Day to Discuss the Company’s Growth Strategy and Deep TMS™ Treatment December 1, 2025
-
-
-
-
-
-
-
BrainsWay invests in two additional US mental health providers
-
327,801 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

